title: The coagulation profile in hepatosplenic schistosomiasis.
abstract: The biological activity of blood coagulation factors II, V, VII, VIII, IX, X, XI and XII, fibrinogen and prekallikrein was assessed in 15 healthy subjects and 60 patients with endemic Egyptian hepatosplenomegaly. The degree of liver disease was graded according to the Child-Pugh classification, the intensity of S. mansoni infection was monitored by determination of circulating schistosome immune complexes (CSIC) level using a monoclonal antibody and hemostasis activation was detected by measurement of hemostatic markers D-dimer and prothrombin fragment 1 + 2 (F1+2). Functional activity of antithrombin III, alpha2-antiplasmin and protein C as well as quantitative determination of plasma concentrations of alpha1-antitrypsin, C1 activator inhibitor and alpha2-macroglobulin were also carried out. The progressive deterioration of liver function which matched the severity of the disease and the intensity of schistosomal infection led to a reduction in anticoagulant proteins (decreases in antithrombin III and protein C) resulting in hypercoagulability and thrombin generation (increased F1+2) subsequently followed by consumption (prolongation of coagulation screening tests, thrombocytopenia, hypofibrinogenemia and decreased factor VIII resulting in hypocoagulability and secondary fibrinolysis (increased D-dimer and decreased alpha2-antiplasmin). A significant decline in fibrinogen and factors VII, XII and prekallikrein was detected in bleeders compared with ascitic patients. The decline in factor XII was closely related to CSIC high titers in all disease groups, but was not correlated to D-dimer or F1+2 concentrations. This suggests that circulating schistosome immune complexes may exert an inhibitory effect on contact factor XII which should be taken into account when considering the reasons for schistosomal coagulopathy and bleeding in hepatosplenic schistosomiasis.
authors.affiliation: Haematology Department, Theodor Bilharz Research Institute, Giza, Egypt.
authors.forename: N E
authors.initials: NE
authors.lastname: El-Bassiouni
authors.forename: A E
authors.initials: AE
authors.lastname: El Bassiouny
authors.forename: N A
authors.initials: NA
authors.lastname: Hussein
authors.forename: H H
authors.initials: HH
authors.lastname: El-Sayed
authors.forename: I M
authors.initials: IM
authors.lastname: Ibrahim
authors.forename: M G
authors.initials: MG
authors.lastname: Lotfy
authors.forename: S A
authors.initials: SA
authors.lastname: Omran
mesh_terms: D000328:Adult; D015415:Biomarkers / Q000097:blood; D001779:Blood Coagulation Factors / Q000378:metabolism*; D016022:Case-Control Studies; D004932:Esophageal and Gastric Varices / Q000150:complications; D006471:Gastrointestinal Hemorrhage / Q000209:etiology; D006801:Humans; D008109:Liver Diseases, Parasitic / Q000097:blood*; D017093:Liver Failure / Q000469:parasitology*; D008875:Middle Aged; D012555:Schistosomiasis mansoni / Q000097:blood*; D013158:Splenic Diseases / Q000097:blood* / Q000469:parasitology
chemical_list: D015415:Biomarkers; D001779:Blood Coagulation Factors